Abstract
This chapter presents an overview of disease screening problems and operations research applications on different aspects of the problem. We first discuss operations research applications in evaluation and optimization of screening policies. Cost-effectiveness analysis and personalized medical decision making approaches for screening problems are be discussed here. The methodologies discussed include microsimulation models, compartmental models, general stochastic models and Partially Observed Markov Decision Processes. Then, organization of screening services for reaching out to the population and improving the effectiveness of screening, is discussed. Main topics included are location and resource allocation problems. We conclude with a brief discussion of future research directions.
References
Akhundov N (2015) Optimal location, patient routing, and capacity decisions for endoscopy clinical network in western ontario: a simulation-based optimization approach. MS Thesis, University of Waterloo
Alagöz O (2014) Chapter 6: Optimizing cancer screening using partially observable Markov decision processes. INFORMS, Catonsville, pp 75–89
Alagöz O, Ayer T, Erenay FS (2011) Operations research models for cancer screening. In: Cochran JJ, Cox LA Jr, Keskinocak P, Kharoufeh JP, Smith JC (eds) Wiley encyclopedia of operations research and management science. Wiley, Hoboken
Alistar S.S., Long EF, Brandeau ML, Beck EJ (2013) Hiv epidemic control—a model for optimal allocation of prevention and treatment resources. Health Care Manag Sci 17(2):162–181
American Cancer Society (2016) Colorectal cancer early detection: acs recommendations. http://www.cancer.org/cancer/colonandrectumcancer/
Andermann A, Blancquaert I, Beauchamp S (2008) Revisiting wilson and jungner in the genomic age: a review of screening criteria over the past 40 years. Bull World Health Organ 86:317–319
Ayer T (2015) Inverse optimization for assessing emerging technologies in breast cancer screening. Ann Oper Res 230:57–85
Ayer T, Alagöz O, Stout NK (2012) Or forum: a pomdp approach to personalize mammography screening decisions. Oper Res 60(5):1019–1034
Ayer T, Alagöz O, Stout NK, Burnside ES (2016) Heterogeneity in womens adherence and its role in optimal breast cancer screening policies. Management Science 62(5):1339–1362
Ayvacı MUS, Alagöz O, Burnside ES (2012) The effect of budgetary restrictions on breast cancer diagnostic decisions. Manuf Serv Oper Manag 14(4):600–617
Baker RD (1998) Use of a mathematical model to evaluate breast cancer screening policy. Health Care Manag Sci 1(2):103–113
Brailsford SC, Davies R, Canning C, Roderick PJ (1998) Evaluating screening policies for the early detection of retinopathy in patients with noninsulin dependent diabetes. Health Care Manag Sci 1(2):115–124
Brailsford SC, Gutjahr WJ, Rauner MS, Zeppelzauer W (2006) Combined discrete-event simulation and ant colony optimisation approach for selecting optimal screening policies for diabetic retinopathy. Comput Manag Sci 4(1):59–83
Brailsford S, Harper P, Sykes J (2012) Incorporating human behaviour in simulation models of screening for breast cancer. Eur J Oper Res 219:491–507
Brandeau ML (2013) OR in public health: a little help can go a long way. In: Operations research and health care policy. Springer International Publishing, New York
Brandeau ML, Zaric GS (2009) Optimal investment in hiv prevention programs: more is not always better. Health Care Manag Sci 12(2):27–37
Brandeau ML, Owens DK, Sox CH, Wachter RM (1993) Screening women of childbearing age for human immunodeficiency virus: a model-based policy analysis. Manag Sci 39(1):72–92
Chen Q, Ayer T, Chhatwal J (2016) Optimal liver cancer surveillance in hepatitis C-infected population (working paper)
Chhatwal J, Alagoz O, Burnside ES (2010) Optimal breast biopsy decision-making based on mammographic features and demographic factors. Oper Res 58(6):1577–1591
CISNET (2016) Cisnet model registry. https://resources.cisnet.cancer.gov/registry/packages/
Davari S, Kılıç K, Naderi S (2016) A heuristic approach to solve the preventive health care problem with budget and congestion constraints. Appl Math Comput 276:442–453
de Kok IMCM, van Rosmalen J, Dillner J, Arbyn M, Sasieni P, Iftner T, van Ballegooijen M (2012) Primary screening for human papillomavirus compared with cytology screening for cervical cancer in european settings: cost effectiveness analysis based on a dutch microsimulation model. BMJ 344:e670
Eagle JN (1984) The optimal search for a moving target when the search path is constrained. Oper Res 32(5):1107–1115
Eddy DM (1980) Screening for cancer: theory analysis and design. Prentice-Hall, Inc., Englewood Cliffs
Eddy DM (1983) Optimal incentives for allocating hiv/aids prevention resources among multiple populations. Med Decis Mak 3(1):45–62
Eddy DM (1990) Screening for colorectal cancer. Ann Intern Med 113(5):373–384
Erenay FS, Alagoz O, Said A (2014) Optimizing colonoscopy screening for colorectal cancer prevention and surveillance. Manuf Serv Oper Manag 16(3):381–400
Erenay FS, Alagoz O, Banerjee R, Said A, Cima RR (2016) Cost-effectiveness of alternative colonoscopy surveillance strategies to mitigate metachronous colorectal cancer incidence. Cancer 122(16):2560–2570
Food and Drug Administration (2011) Compliance guidance: the mammography quality standards act final regulations: preparing for mqsa inspections; final. http://www.fda.gov/RegulatoryInformation/Guidances/ucm094420.htm
Frazier A, Colditz G, Fuchs C, Kuntz K (2000) Cost-effectiveness of screening for colorectal cancer in the general population. JAMA 284(15):1954–1961
Grosse SD (2008) Assessing cost-effectiveness in healthcare: history of the $50,000 per qaly threshold. Expert Rev Pharmacoecon Outcomes Res 8(2):165–178
Gu W, Wang X, McGregor SE (2010) Optimization of preventive health care facility locations. Int J Health Geogr 9(1):1–16
Gulati R, Gore JL, Etzioni R (2013) Comparative effectiveness of alternative prostate-specific antigen-based prostate cancer screening strategies model: estimates of potential benefits and harms. Ann Intern Med 158(3):145–153
Güneş ED, Nickel S (2015) Location problems in healthcare. In: Location science. Springer International Publishing, Cham, pp 555–579
Güneş ED, Chick SE, Akşin OZ (2004) Breast cancer screening services: trade-offs in quality, capacity, outreach, and centralization. Health Care Manag Sci 7(4):291–303
Güneş ED, Örmeci EL, Kunduzcu D (2015) Preventing and diagnosing colorectal cancer with a limited colonoscopy resource. Prod Oper Manag 24(1):1–20
Habbema J, van Oortmarssen G, Lubbe J, van der Maas P (1985) The miscan simulation program for the evaluation of screening for disease. Comput Methods Prog Biomed 20(1):79–93
Harper P, Jones S (2005) Mathematical models for the early detection and treatment of colorectal cancer. Health Care Manag Sci 8:101–109
Heidenberger K (1996) Strategic investment in preventive health care: quantitative modeling for programme selection and resource allocation. OR Spektr 18:1–14
Ivy JS (2009) Can we do better? Optimization models for breast cancer screening. In: Handbook of optimization in medicine. Springer US, Boston, pp 1–28
Jones AP, Homer JB, Murphy DL, Essien JDK, Milstein B, Seville DA (2006) Understanding diabetes population dynamics through simulation modeling and experimentation. Am J Public Health 96(3):488–494
Karanfil, Ö (2016) Why clinical practice guidelines shift over time: a dynamic model with application to prostate cancer screening. PhD Thesis, Massachusetts Institute of Technology
Kirkizlar E, Faissol DM, Griffin PM, Swann JL (2010) Timing of testing and treatment for asymptomatic diseases. Math. Biosci. 26(1):28–37
Lee HL, Pierskalla WP (1988), Mass screening models for contagious diseases with no latent period. Oper Res 36(6):917–928
Lee E, Lavieri MS, Volk ML, Xu Y (2015) Applying reinforcement learning techniques to detect hepatocellular carcinoma under limited screening capacity. Health Care Manag Sci 18:363–375
Leshno M, Halpern Z, Arber N (2003) Cost effectiveness of colorectal cancer screening in the average risk population. Health Care Manag Sci 6(3):165–174
Li Y, Zhu M, Klein R, Kong N (2014) Using a partially observable Markov chain model to assess colonoscopy screening strategies–a cohort study. Eur J Oper Res 238(1):313–326
Li J, Dong M, Ren Y, Yin K (2015) How patient compliance impacts the recommendations for colorectal cancer screening. J Comb Optim 30:920–937
Lincoln T, Weiss GH (1964) A statistical evaluation of recurrent medical examinations. Oper Res 12(2):187–205
Loeve F, Boer R, van Oortmarssen GJ, van Ballegooijen M, Habbema JDF (1999) The miscan-colon simulation model for the evaluation of colorectal cancer screening. Comput Biomed Res 32:13–33
Lovejoy WS (1991) A survey of algorithmic methods for partially observed markov decision processes. Ann Oper Res 28(1):47–65
Macafee D, Waller M, Whynes D, Moss S, Scholefield J (2008) Population screening for colorectal cancer: the implications of an ageing population. Br J Cancer 99:1991–2000
Madadi M, Zhang S, Henderson LM (2015) Evaluation of breast cancer mammography screening policies considering adherence behavior. Eur J Oper Res 247:630–640
Maillart LM, Ivy JS, Ransom S, Diehl K (2008) Assessing dynamic breast cancer screening policies. Oper Res 56(6):1411–1427
Malvankar-Mehta MS, Xie B (2012) Optimal incentives for allocating hiv/aids prevention resources among multiple populations. Health Care Manag Sci 15(4):327–338
McLay LA, Foufoulides C, Merrick JRW (2010) Using simulation-optimization to construct screening strategies for cervical cancer. Health Care Manag Sci 13(4):294–318
McMahon PM, Kong CY, Bouzan C, Weinstein MC, Cipriano LE, Tramontano AC, Johnson BE, Weeks JC, Gazelle GS (2011) Cost-effectiveness of computed tomography screening for lung cancer in the united states. J Thorac Oncol 6(11):1841 – 1848
Monahan GE (1982) A survey of partially observable markov decision processes: theory, models, and algorithms. Manag Sci 28(1):1–16
Önen Z, Sayın S, Gurvit IH (2016) Optimal population screening policies for alzheimer’s disease. Working Paper, Koç University
Örmeci EL, Güneş ED, Kunduzcu D (2015) A modeling framework for control of preventive services. Manuf Serv Oper Manag 18(2):227–244
Özekici S, Pliska SR (1991) Optimal scheduling of inspections: a delayed markov model with false positives and negatives. Oper Res 39(2):261–273
Parmigiani G (1996) Optimal scheduling of fallible inspections. Oper Res 44(2):360–367
Price, S, Golden B, Wasil E, Denton BT (2016) Operations research models and methods in the screening, detection, and treatment of prostate cancer: a categorized, annotated review. Manuf Serv Oper Manag 8:9–21
Rauner M, Gutjahr W, Heidenberger K, Wagner J, Pasia J (2010) Dynamic policy modeling for chronic diseases: metaheuristic-based identification of pareto-optimal screening strategies. Oper Res 58(5):1269–1286
Rutter CM, Zaslavsky A, Feuer E (2011) Dynamic microsimulation models for health outcomes: a review. Med Decis Mak 31(1):10–18
Shwartz M (1978) A mathematical model used to analyze breast cancer screening strategies. Oper Res 26(6):937–955
Siebert U, Sroczynski G, Hillemanns P, Engel J, Stabenow R, Stegmaier C, Voigt K, Gibis B, Hölzel D, Goldie SJ (2006) The german cervical cancer screening model: development and validation of a decision-analytic model for cervical cancer screening in germany. Eur J Pub Health 16(2):185–192
Siebert U, Alagoz O, Bayoumi AM, Jahn B, Owens DK, Cohen DJ, Kuntz KM (2012) State-transition modeling: a report of the ispor-smdm modeling good research practices task force-3. Value Health 15(6):812–820
Smallwood RD, Sondik EJ (1973) The optimal control of partially observable markov processes over a finite horizon. Oper Res 21(5):1071–1088
Steimle LN, Denton BT (2017) Markov decision processes for screening and treatment of chronic diseases. In Markov Decision Processes in Practice (pp. 189–222). Springer International Publishing.
Szeto KL, Devlin NJ (1996) The cost-effectiveness of mammography screening: evidence from a microsimulation model for New Zealand. Health Policy 38(2):101–115
Tejada JJ, Ivy JS, King RE, Wilson JR, Ballan MJ, Kay MG, Diehl KM, Yankaskas BC (2014) Combined des/sd model of breast cancer screening for older women, ii: screening-and-treatment simulation. IIE Trans 46(7):707–727
van Ballegooijen M, Habbema JD, van Oortmarssen GJ, Koopmanschap MA, Lubbe JT, van Agt HM (1992) Preventive pap-smears: balancing costs, risks and benefits. Br J Cancer 65(6): 930–933
Verter V, Lapierre S (2002) Location of preventive health care facilities. Ann Oper Res 110(1):123–132
Verter V, Zhang Y (2015) Location models for preventive care. In: Applications of location analysis. Springer International Publishing, Cham, pp 223–241
Vieira IT, de Senna V, Harper PR, Shahani AK (2011) Tumour doubling times and the length bias in breast cancer screening programmes. Health Care Manag Sci 14(2):203–211
Voelker JA, Pierskalla WP (1980) Test selection for a mass screeening program. Nav Res Logist 27:43–55
Waugh N, Scotland G, McNamee P, Gillett M, Brennan A (2007) Screening for type 2 diabetes: literature review and economic modelling. Health Technol Assess 11(17):144
Wilson JMG, Jungner G (1968) Principles and practice of screening for disease. World Health Organization, Geneva
Wilson R, Liston J (2011) Quality assurance guidelines for breast cancer screening radiology, Volume NHSBSP Publication No 59. NHS Cancer Screening Programmes
Yang Y, Goldhaber-Fiebert JD, Wein LM (2013) Analyzing screening policies for childhood obesity. Manag Sci 59(4):782–795
Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM (2008) Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. preventive services task force. Ann Intern Med 149(9):659–669
Zelen M, Feinleib M (1969) On the theory of screening for chronic diseases. Biometrika 56(3):601–614
Zhang Y, Berman O, Verter V (2009) Incorporating congestion in preventive healthcare facility network design. Eur J Oper Res 198(3):922–935
Zhang Y, Berman O, Marcotte P, Verter V (2010) A bilevel model for preventive healthcare facility network design with congestion. IIE Trans 42(12):865–880
Zhang Y, Berman O, Verter V (2012) The impact of client choice on preventive healthcare facility network design. OR Spectr 34(2):349–370
Zhang J, Denton BT, Balasubramanian H, Shah ND, Inman BA (2012a) Optimization of prostate biopsy referral decisions. Manuf Serv Oper Manag 14(4):529–547
Zhang J, Denton BT, Balasubramanian H, Shah ND, Inman BA (2012b) Optimization of psa screening policies: a comparison of the patient and societal perspectives. Med Decis Mak 32(2):337–349
Zhang Y, Denton BT, Nielsen ME (2013) Comparison of surveillance strategies for low-risk bladder cancer patients. Med Dec Mak 33(2):198–214
Zhang J, Mason JE, Denton BT, Pierskalla WP (2013) Disease prevention, detection, and treatment. In: Cochran JJ, Cox LA Jr, Keskinocak P, Kharoufeh JP, Smith JC (eds) Encyclopedia of operations research and management science. Springer US, New York, pp 437–447.
Zimmerman S (1997) Factors influencing hispanic participation in prostate cancer screening. Oncol Nurs Forum 24:499–504
Acknowledgements
The authors gratefully acknowledge the feedback they received from Oguzhan Alagoz, Turgay Ayer, Brian Denton, Fatih Safa Erenay, Paul Harper, Evin Uzun Jacobson, Ozge Karanfil, and two anonymous reviewers, which helped improve the chapter significantly.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Güneş, E.D., Örmeci, E.L. (2018). OR Applications in Disease Screening. In: Kahraman, C., Topcu, Y. (eds) Operations Research Applications in Health Care Management. International Series in Operations Research & Management Science, vol 262. Springer, Cham. https://doi.org/10.1007/978-3-319-65455-3_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-65455-3_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-65453-9
Online ISBN: 978-3-319-65455-3
eBook Packages: Business and ManagementBusiness and Management (R0)